CONNECT WITH US

Tech

Paediatric healthcare startup Hoola Health raises $5 Mn led by Peak XV’s Surge

Published on

Paediatric healthcare startup Hoola Health raises $5 Mn led by Peak XV’s Surge

Paediatric healthcare startup Hoola Health, formerly known as BabyMD, has raised $5 million in a funding round led by Peak XV’s Surge, with participation from existing investor W Health Ventures and angel investors including Ashish Gupta, Abhishek Goyal, and Bijou Kurien.

The fresh capital will be used to expand into new markets, strengthen technology capabilities, and scale its integrated paediatric care model, th

Founded in 2024 by Deeksha Senguttuvan, Hoola Health operates child-focused clinics offering paediatric consultations, vaccinations, diagnostics, developmental therapies, and specialist care. 

The startup combines physical clinics with digital tools for vaccination records, growth tracking, prescriptions, and developmental monitoring.

The Bengaluru-based firm currently operates five clinics and has served more than 20,000 families within 18 months of launch. According to the startup, over 60% of new patients come through word-of-mouth referrals, while more than 60% of monthly visits are from returning families.

Hoola Health claims that nearly 35% of its revenue comes from developmental therapies, reflecting growing demand for integrated child healthcare services.

The company plans to open 30 additional clinics across Bengaluru, Hyderabad, and Delhi NCR over the next two years. It also intends to expand into new services, including paediatric dental care.

Alongside the funding announcement, the startup has rebranded from BabyMD to Hoola Health as it looks to broaden its presence across different stages of child healthcare and development.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Google Preferred Source